期刊文献+
共找到970篇文章
< 1 2 49 >
每页显示 20 50 100
Analysis of mechanism of Buzhong Yiqi Decoction in treating senile functional constipation via network pharmacology
1
作者 Jia-Yong Shi Guan-Cheng Zhang +4 位作者 Tian-Wei Xia Shen-Yan Cai Qiao-Jing Yan Xing-Bao Wang Xue-Ping Zheng 《Journal of Hainan Medical University》 2020年第24期47-52,共6页
Objective:To explore the molecular mechanism of buzhong yiqi decoction in the treatment of senile functional constipation based on network pharmacology.Methods:Chemical compositions and selected targets related to the... Objective:To explore the molecular mechanism of buzhong yiqi decoction in the treatment of senile functional constipation based on network pharmacology.Methods:Chemical compositions and selected targets related to the eight traditional Chinese medicine herbs were searched through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP).Through GeneCards database and OMIM database,disease targets of senile functional constipation were searched.R language was used to screen the common targets between drugs and disease,and then the interaction network diagram of the targets was constructed by String.Cytoscape3.7.0 was applied to construct the traditional Chinese medicines-chemical compositions-disease targets network.GO enrichment analysis and KEGG enrichment analysis of the targets were based on DAVID.Results:Five main chemical compositions including quercetin,kaempferol,nobiletin,naringenin and formononetin were screened,and five key targets including PTGS2,ESR1,AR,NOS2 and PPARG were identified.622 GO functional entries and 125 pathways were yielded by gene enrichment analysis.Conclusion:Buzhong yiqi decoction may play the role of anti-inflammatory and anti-oxidation through multi-component,multi-target and multi-channel,so as to improve senile functional constipation. 展开更多
关键词 Network pharmacology buzhong yiqi decoction Senile functional constipation MECHANISM
在线阅读 下载PDF
Therapeutic effects of Buzhong Yiqi decoction in patients with spleen and stomach qi deficiency after routine surgery and chemotherapy for colorectal cancer
2
作者 Qi Hu Xiao-Pin Chen +2 位作者 Zhi-Jun Tang Xue-Yuan Zhu Chun Liu 《World Journal of Gastrointestinal Surgery》 SCIE 2024年第7期2183-2193,共11页
BACKGROUND According to the theory of traditional Chinese medicine(TCM),the spleen and stomach are the basis of acquired nature and the source of qi and blood biochemistry.After surgery and chemotherapy,patients with ... BACKGROUND According to the theory of traditional Chinese medicine(TCM),the spleen and stomach are the basis of acquired nature and the source of qi and blood biochemistry.After surgery and chemotherapy,patients with colorectal cancer often develop spleen and stomach qi deficiency syndrome,leading to decreased immune function.Buzhong Yiqi decoction,a classic TCM prescription,has the effect of tonifying middle-jiao and invigorating qi,boosting Yang,and suppressing immune-related inflammation.Moreover,it is widely used in the treatment of spleen and stomach qi deficiency syndrome.AIM To investigate the effect of Buzhong Yiqi decoction on spleen and stomach qi deficiency in patients with colorectal cancer.METHODS One hundred patients with colorectal cancer who underwent preoperative chemotherapy and laparoscopy at The First TCM Hospital of Changde from January 2022 to October 2023 were retrospectively analyzed.The patients were divided equally into control and observation groups.Both groups underwent conventional rehabilitation surgery,and the observation group was supplemented with Buzhong Yiqi decoction.SPSS 26.0 was used for statistical analyses.Theχ2 test was used for univariate analysis;independent sample t-tests were used in all cases.RESULTS No significant differences were observed preoperatively in the general characteristics of the two groups.Fourteen days post-surgery,the abdominal distension,emaciation,loose stool,loss of appetite,and vomiting scores were significantly lower in the observation group than in the control group(P<0.05).Immune function and interleukin(IL)-10 levels in the observation group were significantly higher than those of the control group,whereas IL-6,tumor necrosis factor-α,and C-reactive protein levels,tumor biological indexes,and adverse reactions in the observation group were significantly lower than those of the control group(P<0.05).One month after surgery,the patients’quality of life in the observation group was significantly higher than that of the patients in the control group(P<0.05).CONCLUSION Buzhong Yiqi decoction can regulate inflammatory responses and metabolic processes by enhancing immune function,thereby promoting overall immune nutrition and restoring the body’s balance. 展开更多
关键词 buzhong yiqi decoction Colorectal cancer Laparoscopic radical surgery Immune function Inflammatory mediators SPLEEN
在线阅读 下载PDF
Clinical Observation of Jiawei Buzhong Yiqi Decoction in the Treatment of Obese Polycystic Ovarian Syndrome 被引量:1
3
作者 Chenggang LI Li ZHOU +1 位作者 Shuang LI Xiao LI 《Medicinal Plant》 CAS 2018年第6期94-96,100,共4页
[Objectives] To observe the clinical efficacy of Jiawei Buzhong Yiqi Decoction in the treatment of polycystic ovarian syndrome(PCOS).[Methods]Obese patients with PCOS were recruited for the study in September 2014-Dec... [Objectives] To observe the clinical efficacy of Jiawei Buzhong Yiqi Decoction in the treatment of polycystic ovarian syndrome(PCOS).[Methods]Obese patients with PCOS were recruited for the study in September 2014-December 2016 from Chinese medicine gynecological clinic in the affiliated hospital of Hubei University of Medicine.All these patients were given one dose of Jiawei Buzhong Yiqi Decoction one time a day for three months.Body mass index(BMI) was measured before and after treatment.Sex hormone levels and ovulation were measured,and the improvement of clinical symptoms was compared before and after treatment.[Results] After treatment,the levels of BMI and serum luteinizing hormone(LH),testosterone(T) were significantly decreased,and the level of serum estradiol(E2) was significantly higher than that before treatment.Ovarian enlargement and polycystic changes,menstrual cycle,menstrual flow and menstrual period were improved in varying degrees.[Conclusions] Jiawei Buzhong Yiqi Decoction has a good clinical effect in the treatment of obese PCOS. 展开更多
关键词 Jiawei buzhong yiqi decoction POLYCYSTIC OVARIAN syndrome(PCOS) Body mass index(BMI) Sex HORMONE
在线阅读 下载PDF
Effect of Buzhong Yiqi Decoction (补中益气汤) on Murine Liver Damage Induced by Food Allergy 被引量:1
4
作者 陈虹 董阳深 +4 位作者 陈奋华 纪经智 陈岩峰 上野幸三 饭仓洋治 《Chinese Journal of Integrated Traditional and Western Medicine》 2004年第1期55-58,共4页
Objective: To investigate the effect of Buzhong Yiqi decoction (补中益气汤, BZYQD) on liver damage induced by food allergy in mice. Methods: Nc/Jic strain mice with high levels of serum IgE were sensitized by ovalbumi... Objective: To investigate the effect of Buzhong Yiqi decoction (补中益气汤, BZYQD) on liver damage induced by food allergy in mice. Methods: Nc/Jic strain mice with high levels of serum IgE were sensitized by ovalbumin (OVA), and then divided into two groups and respectively treated with BZYQD (treated group) or normal saline (model group). Samples of serum, liver tissues and small intestine were collected two weeks later, and another group of non-sensitized mice was set as the normal group. The levels of serum alanine aminotransferase (ALT) were measured with spectrophotometry. The liver tissue and small intestine were stained with hematoxylin and eosin (HE) for pathologic analysis. The liver samples were also subjected to analysis of CD4-T helper cell and cytokine (interleukin-4, IL-4, interleukin-6, IL-6) expression with immunohistochemical (avidin-biotin complex, ABC) method. Results: Serum ALT levels decreased and obvious pathologic improvements were seen in the mice treated with BZYQD. And compared with the model mice, the number of positive cells of IL-4, IL-6 and CD4 cell decreased significantly in those treated with BZYQD. Conclusion: BZYQD can effectively decrease the production of cytokines associated with allergic reaction in the liver of mice thus effective in treating liver damage caused by food allergy. 展开更多
关键词 food allergy liver damage buzhong yiqi decoction
在线阅读 下载PDF
Effects of Jiawei Buzhong Yiqi Decoction on the Endometrial Receptivity of Rats with Polycystic Ovary Syndrome 被引量:1
5
作者 Chen ZHAO Chenggang LI 《Medicinal Plant》 CAS 2021年第6期46-49,55,共5页
[Objectives]The study aims to discuss the effects of Jiawei Buzhong Yiqi Decoction on the endometrial receptivity of rats with polycystic ovarian syndrome(PCOS).[Methods]Adult female SD rats were selected and randomly... [Objectives]The study aims to discuss the effects of Jiawei Buzhong Yiqi Decoction on the endometrial receptivity of rats with polycystic ovarian syndrome(PCOS).[Methods]Adult female SD rats were selected and randomly divided into the model group and control group.In the model group,the PCOS model was established by using the method of Poretsky L.Rats in the control group were given physiological saline intervention at the same time.The successfully modeled rats were randomly divided into the PCOS group and traditional Chinese medicine group.Among them,rats in the Chinese medicine group were given Jiawei Buzhong Yiqi Decoction by gavage;rats in the model group and the control group were given normal saline for 14 d.All rats were killed by anesthesia after the last administration,and serum and uterine specimens were collected.Serum sex hormones(including T,E_(2),and P),glucose and insulin levels were detected;the equivalent diameter and area of endometrial gland and gland cavity,and the endometrial thickness of rats were measured;the expression of endometrial leukemia inhibitory factor(LIF),integrinαvβ3 protein and mRNA was detected by using Elisa and RT-PCR methods.[Results]The serum T,glucose,and insulin levels of rats in the PCOS group were significantly higher than those of the control group and the traditional Chinese medicine group,and there was no significant difference in the above indicators between the control group and the traditional Chinese medicine group;there was no significant difference in the E_(2) and P levels between the three groups.The equivalent diameter and area of endometrial gland and gland cavity,and the endometrial thickness of rats in the PCOS group were lower than those of the control group and the traditional Chinese medicine group;there was no significant difference in the above indicators between the traditional Chinese medicine group and the control group.The expression of LIF,integrinαvβ3 protein and mRNA in the endometrium of rats in various groups was basically the same.The expression of LIF and integrinαvβ3 in the endometrium of rats in the PCOS group was significantly lower than that of the control group and the traditional Chinese medicine group;there was no significant difference in the above indicators between the control group and the traditional Chinese medicine group.[Conclusions]The endometrial receptivity of PCOS rats was decreased;Jiawei Buzhong Yiqi Decoction can improve the endometrial receptivity of PCOS rats by increasing the expression of LIF and integrinαvβ3 in the endometrium. 展开更多
关键词 Jiawei buzhong yiqi decoction Polycystic ovary syndrome Leukemia inhibitory factor Integrinαvβ3
在线阅读 下载PDF
Combined Treatment with Bojungikgi-tang(Buzhong Yiqi Decoction)and Riluzole Attenuates Cell Death in TDP-43-Expressing Cells
6
作者 Eun Jin Yang 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2024年第7期616-622,共7页
Objective To examine the effect of combined treatment with Bojungikgi-tang(BJIGT,Buzhong Yiqi Decoction)and riluzole(RZ)in transactive response DNA-binding protein 43(TDP-43)stress granule(SG)cells,a amyotrophic later... Objective To examine the effect of combined treatment with Bojungikgi-tang(BJIGT,Buzhong Yiqi Decoction)and riluzole(RZ)in transactive response DNA-binding protein 43(TDP-43)stress granule(SG)cells,a amyotrophic lateral sclerosis(ALS)cell line using transcriptomic and molecular techniques.Methods TDP-43 SG cells were pretreated with BJIGT(100µg/mL),RZ(50µmol/L),and combined BJIGT(100µg/mL)/RZ(50µmol/L)for 6 h before treatment with lipopolysaccharide(LPS,200µmol/L).Cell viability assay was performed to elucidate cell toxicity in TDP-43 SC cells using a cell-counting kit-8(CCK8)assay kit.The expression levels of cell death-related proteins,including Bax,caspase 1,cleaved caspase 3 and DJ1 in TDP-43 SG cells were examined by Western blot analysis.The autophagy-related proteins,including pmTOR/mTOR,LC3b,P62,ATG7 and Bcl-2-associated athanogene 3(Bag3)were investigated using immunofluorescence and immunoblotting assays.Results Cell viability assay and Western blot analysis showed that combined treatment with BJIGT and RZ suppressed LPS-induced cell death and expression of cell death-related proteins,including Bax,caspase 1,and DJ1(P<0.05 or P<0.01).Immunofluorescence and immunoblotting assays showed that combined treatment with BJIGT and RZ reduced LPS-induced formation of TDP-43 aggregates and regulated autophagy-related protein levels,including p62,light chain 3b,Bag3,and ATG7,in TDP-43-expressing cells(P<0.05 or P<0.01).Conclusion The combined treatment of BJIGT and RZ might reduce inflammation and regulate autophagy dysfunction in TDP-43-induced ALS. 展开更多
关键词 Bojungikgi-tang buzhong yiqi decoction transactive response DNA-binding protein 43 AUTOPHAGY oxidative stress amyotrophic lateral sclerosis
原文传递
补中益气汤对晚期非小细胞肺癌术后化疗患者的临床疗效
7
作者 李贵新 李爽 +4 位作者 高志成 张春雷 宋鹏 常炳龙 王鹏 《中成药》 北大核心 2025年第2期463-466,共4页
目的探讨补中益气汤对晚期非小细胞肺癌术后化疗患者的临床疗效。方法86例患者随机分为对照组和观察组,每组43例,对照组给予GP化疗方案,观察组在对照组基础上加用补中益气汤。检测近远期疗效、KPS评分、PFS评分、免疫功能指标(CD4^(+)、... 目的探讨补中益气汤对晚期非小细胞肺癌术后化疗患者的临床疗效。方法86例患者随机分为对照组和观察组,每组43例,对照组给予GP化疗方案,观察组在对照组基础上加用补中益气汤。检测近远期疗效、KPS评分、PFS评分、免疫功能指标(CD4^(+)、CD8^(+)、CD4^(+)/CD8^(+))、肿瘤标志物(CEA、CA125、CYFRA21-1)、毒副反应发生率变化。结果观察组总有效率、中位PFS高于对照组(P<0.05),胃肠道反应、白细胞减少、血小板减少、体质量减轻发生率更低(P<0.05)。治疗后,2组KPS评分升高(P<0.05),PFS评分、肿瘤标志物降低(P<0.05),以观察组更明显(P<0.05);观察组免疫功能指标升高(P<0.05),并高于对照组(P<0.05)。结论补中益气汤可安全有效地提高晚期非小细胞肺癌术后化疗患者临床疗效和生活质量,改善癌因性疲乏,调节免疫功能,降低肿瘤标志物水平。 展开更多
关键词 补中益气汤 GP化疗方案 晚期非小细胞肺癌 化疗 增效减毒 癌因性疲乏
在线阅读 下载PDF
补中益气加味方对结直肠癌移植瘤模型Vimentin、E-cadherin表达的研究
8
作者 王伟 胡凡 +5 位作者 谢彪 邓未 叶鑫 周望潮 朱俊芝 李梅 《云南中医中药杂志》 2025年第1期73-77,共5页
目的结合课题组前期临床观察实践以及网络药理学分析结果,探讨补中益气加味方对结直肠癌裸鼠移植瘤组织Vimentin、E-cadherin表达的研究。方法于30只裸鼠右腿内侧皮下接种人结肠癌细胞SW480构建结直肠癌移植瘤模型,随机分为5组,模型对照... 目的结合课题组前期临床观察实践以及网络药理学分析结果,探讨补中益气加味方对结直肠癌裸鼠移植瘤组织Vimentin、E-cadherin表达的研究。方法于30只裸鼠右腿内侧皮下接种人结肠癌细胞SW480构建结直肠癌移植瘤模型,随机分为5组,模型对照组(生理盐水)、补中益气加味方低、中、高浓度组(26.72、53.43、106.86 g·kg^(-1)),4组均每天灌胃给药,连续14 d,化疗组(腹腔注射氟尿嘧啶25mg·kg^(-1))隔天给药1次,连续14 d后处死裸鼠,免疫组化法检测肿瘤组织中Vimentin、E-cadherin蛋白的表达情况。结果模型对照组、低浓度干预组Vimentin高表达,氟尿嘧啶干预组、中浓度和高浓度药物干预组Vimentin表达下调(P<0.05);模型对照组、低浓度干预组E-cadherin低表达,氟尿嘧啶干预组、中浓度和高浓度药物干预组E-cadherin表达上调(P<0.05)。结论补中益气加味方可通过下调EMT标志物Vimentin的表达,上调E-cadherin有效抑制肿瘤细胞侵袭转移。 展开更多
关键词 补中益气加味方 结直肠癌 E-CADHERIN VIMENTIN
在线阅读 下载PDF
益气聪明汤加减方防治药源性及老年性耳聋的作用及机制初探
9
作者 陈伟强 杨艾霖 +5 位作者 林粤圣 余冲 袁旭江 温露 张明 陈钢 《广东药科大学学报》 2025年第1期99-107,共9页
目的 探究益气聪明汤加减方对药源性及老年性耳聋的防治作用并初步探索其作用机制。方法 采用斑马鱼模型,利用卡那霉素、顺铂和过氧化氢(H2O2)建立毛细胞损伤模型,统计毛细胞荧光面积来评价益气聪明汤加减方的毛细胞保护作用。利用豚鼠... 目的 探究益气聪明汤加减方对药源性及老年性耳聋的防治作用并初步探索其作用机制。方法 采用斑马鱼模型,利用卡那霉素、顺铂和过氧化氢(H2O2)建立毛细胞损伤模型,统计毛细胞荧光面积来评价益气聪明汤加减方的毛细胞保护作用。利用豚鼠动物模型,通过卡那霉素、顺铂和D-半乳糖建立豚鼠耳聋模型,检测听力阈值变化和观察耳蜗基底膜毛细胞来评价益气聪明汤加减方的防治作用。通过网络药理学初步探究其作用机制。结果 斑马鱼模型中,益气聪明汤加减方质量浓度在1.0~2.0 mg/mL时,能显著降低卡那霉素、顺铂和H2O2诱导的毛细胞损伤(P<0.05,P<0.01);豚鼠模型中,益气聪明汤加减方高剂量组能显著降低卡那霉素、顺铂和D-半乳糖诱导的听力损失(P<0.01),低剂量组能显著降低D-半乳糖诱导的听力损失(P<0.01);网络药理学筛选出5个主要活性成分、5个核心靶点、915个GO条目、153条KEGG通路,包括AGE-RAGE信号通路、MAPK信号通路等。结论 益气聪明汤加减方对药源性及老年性耳聋能起到明显的防治作用,其机制可能与调控AGE-RAGE信号通路、MAPK信号通路等相关。 展开更多
关键词 益气聪明汤加减方 药源性耳聋 老年性耳聋 网络药理学
在线阅读 下载PDF
补中益气汤加减治疗慢性肾炎蛋白尿的临床效果研究
10
作者 王艳艳 《中国现代药物应用》 2025年第5期140-142,共3页
目的分析补中益气汤加减在慢性肾炎蛋白尿中的治疗效果。方法选择慢性肾炎蛋白尿患者68例为研究对象,随机分成对照组和观察组,每组34例。对照组给予西药治疗,观察组给予补中益气汤加减治疗。比较两组肾功能指标水平、临床疗效、蛋白尿... 目的分析补中益气汤加减在慢性肾炎蛋白尿中的治疗效果。方法选择慢性肾炎蛋白尿患者68例为研究对象,随机分成对照组和观察组,每组34例。对照组给予西药治疗,观察组给予补中益气汤加减治疗。比较两组肾功能指标水平、临床疗效、蛋白尿复发情况。结果治疗后,观察组血尿素氮(7.13±1.02)mmol/L、血肌酐(135.28±22.47)μmol/L、24 h尿蛋白定量(0.49±0.24)g/24 h均低于对照组的(8.46±1.49)mmol/L、(161.48±21.03)μmol/L、(0.78±0.38)g/24 h(P<0.05)。观察组治疗总有效率97.06%高于对照组的79.41%(P<0.05)。随访6个月,观察组蛋白尿复发率2.94%低于对照组的17.65%(P<0.05)。结论采用补中益气汤加减能够使慢性肾炎蛋白尿患者的肾功能指标有效改善,有效提高治疗效果,降低蛋白尿复发率。 展开更多
关键词 慢性肾炎 蛋白尿 补中益气汤加减 临床效果
在线阅读 下载PDF
脐灸联合补中益气汤加减治疗气虚型便秘疗效观察
11
作者 刘伟花 赵蓉 +8 位作者 娄艳芳 秦娜 曹蓉 霍萌 祁爱风 刘素芳 张艳霞 邢峰丽 白雪艳 《北京中医药》 2025年第2期228-232,共5页
目的探讨脐灸联合补中益气汤加减治疗气虚型便秘的疗效。方法选取2020年1月—2022年1月本院收治的234例气虚型便秘患者,采用随机数字表法分为联合组、脐灸组、汤药组,各78例。脐灸组给予常规治疗+脐灸治疗,汤药组给予常规治疗+补中益气... 目的探讨脐灸联合补中益气汤加减治疗气虚型便秘的疗效。方法选取2020年1月—2022年1月本院收治的234例气虚型便秘患者,采用随机数字表法分为联合组、脐灸组、汤药组,各78例。脐灸组给予常规治疗+脐灸治疗,汤药组给予常规治疗+补中益气汤加减治疗,联合组给予常规治疗+脐灸+补中益气汤治疗。3组均以14 d为1个疗程,共治疗3个疗程。对比2组疗效,治疗前后症状评分、肛肠动力学指标及血清血管活性肠肽(VIP)、胃动素(MTL)水平,不良反应。结果联合组总有效率高于脐灸组、汤药组(P<0.05)。治疗后,3组便秘症状评分均较治疗前降低,且联合组便秘症状评分均低于脐灸组、汤药组(P<0.05)。治疗后,3组肛肠动力学指标均较治疗前降低(P<0.05),且联合组肛肠动力学指标均低于脐灸组、汤药组(P<0.05)。治疗后,3组血清VIP、MTL水平均较治疗前改善(P<0.05),且联合组血清VIP水平低于脐灸组、汤药组(P<0.05),血清MTL水平高于脐灸组、汤药组(P<0.05)。联合组、脐灸组、汤药组不良反应发生率比较差异无统计学意义(P>0.05)。结论脐灸联合补中益气汤加减治疗气虚型便秘效果良好,可显著改善便秘症状,恢复肛肠动力学状态,改善血清VIP、MTL水平,且未显著增加不良反应。 展开更多
关键词 气虚型便秘 补中益气汤 脐灸 血管活性肠肽 胃动素
在线阅读 下载PDF
补中益气汤加减治疗脊髓损伤后神经源性肠道功能障碍的临床效果
12
作者 宋为民 张坤 季恩敏 《临床医学研究与实践》 2025年第5期101-104,共4页
目的观察补中益气汤加减治疗脊髓损伤后神经源性肠道功能障碍的临床效果。方法选取2020年7月至2021年12月在我院进行康复治疗的66例脊髓损伤后神经源性肠道功能障碍患者为研究对象,以随机抽签法将其分为对照组(33例,常规康复训练)和研究... 目的观察补中益气汤加减治疗脊髓损伤后神经源性肠道功能障碍的临床效果。方法选取2020年7月至2021年12月在我院进行康复治疗的66例脊髓损伤后神经源性肠道功能障碍患者为研究对象,以随机抽签法将其分为对照组(33例,常规康复训练)和研究组(33例,在对照组基础上予以补中益气汤加减治疗)。比较两组的治疗效果。结果治疗后,研究组的神经源性肠功能障碍(NBD)、Wexner便秘及Wexner肛门失禁评分低于对照组(P<0.05)。治疗后,研究组的每次排便时间短于对照组,排便频率高于对照组(P<0.05)。治疗后,研究组的肛门收缩压、直肠压力、直肠肛管压力差高于对照组,便意阈值低于对照组(P<0.05)。结论补中益气汤加减治疗脊髓损伤后神经源性肠道功能障碍患者的效果理想,可改善肠道症状,调节肛肠内压,降低便意阈值,促进排便顺畅。 展开更多
关键词 补中益气汤 脊髓损伤 神经源性肠道功能障碍
在线阅读 下载PDF
补中益气汤对A549和A549/DDP细胞顺铂敏感性影响差异研究
13
作者 黄婧漪 刘玥彤 +3 位作者 李贺 牟琪瑞 于丹 高原 《辽宁中医药大学学报》 2025年第2期13-18,共6页
目的 探讨补中益气汤对A549和A549/DDP细胞的顺铂敏感性影响的差异性,并确定给药最佳剂量。方法 培养A549、A549/DDP细胞,不同浓度顺铂作用后应用CCK-8法检测各组生长抑制率;制备低、中、高剂量补中益气汤含药血清,随机分为24组:A549细... 目的 探讨补中益气汤对A549和A549/DDP细胞的顺铂敏感性影响的差异性,并确定给药最佳剂量。方法 培养A549、A549/DDP细胞,不同浓度顺铂作用后应用CCK-8法检测各组生长抑制率;制备低、中、高剂量补中益气汤含药血清,随机分为24组:A549细胞(5%空白血清组、10%空白血清组、20%空白血清组、5%低剂量含药血清组、10%低剂量含药血清组、20%低剂量含药血清组、5%中剂量含药血清组、10%中剂量含药血清组、20%中剂量含药血清组、5%高剂量含药血清组、10%高剂量含药血清组、20%高剂量含药血清组),A549/DDP细胞(5%空白血清组、10%空白血清组、20%空白血清组、5%低剂量含药血清组、10%低剂量含药血清组、20%低剂量含药血清组、5%中剂量含药血清组、10%中剂量含药血清组、20%中剂量含药血清组、5%高剂量含药血清组、10%高剂量含药血清组、20%高剂量含药血清组),应用CCK-8法检测各组A549、A549/DDP细胞生长抑制情况及生长抑制率,应用Annexin V-FITC/PI染色法检测各组细胞凋亡率。结果 顺铂对A549、A549/DDP细胞的最佳抑制浓度均为20μg/mL;10%中剂量补中益气汤对A549细胞顺铂的凋亡率和生长抑制率最为显著,相比而言,20%高剂量补中益气汤对A549/DDP细胞的作用最为显著。结论 与A549细胞相比,A549/DDP细胞需要更高浓度更高剂量的补中益气汤含药血清才能发挥最佳顺铂增敏效果,说明补中益气汤对A549细胞的顺铂增敏作用强于A549/DDP细胞。 展开更多
关键词 补中益气汤 顺铂 A549细胞 A549/DDP细胞 非小细胞肺癌
在线阅读 下载PDF
连建伟教授对右关脉虚大的脉理探析及诊治经验
14
作者 彭少文 汪玲羽 +1 位作者 陈宛芸 张咩庆 《中国民族民间医药》 2025年第4期101-103,共3页
文章总结了连建伟教授临床上对于右关脉象虚大的诊治经验。连建伟教授传承东垣重脾胃的思想,精于脉诊,临证脉证合参,重视右关脉象的变化。连建伟教授认为右关虚大为右关部脉出现脉体宽大,举之无力,按之空霍之象。右关脉虚大者,多属脾胃... 文章总结了连建伟教授临床上对于右关脉象虚大的诊治经验。连建伟教授传承东垣重脾胃的思想,精于脉诊,临证脉证合参,重视右关脉象的变化。连建伟教授认为右关虚大为右关部脉出现脉体宽大,举之无力,按之空霍之象。右关脉虚大者,多属脾胃虚弱,中气不足,遵“劳者温之,损者益之”之义,连建伟教授常以补中益气汤加减治之。 展开更多
关键词 连建伟 右关脉虚大 脉诊 名医经验 补中益气汤
在线阅读 下载PDF
腹腔镜无张力疝修补术联合补中益气汤治疗腹股沟疝临床观察
15
作者 颜贵武 江玲玲 《中国中医药现代远程教育》 2025年第1期166-168,共3页
目的探讨应用腹腔镜无张力疝修补术联合补中益气汤治疗腹股沟疝的临床效果。方法选择2020年1月—2021年12月的腹股沟疝患者90例作为观察对象,根据入院顺序随机分组,对照组(45例)接受单纯的腹腔镜无张力疝修补术治疗,研究组(45例)接受腹... 目的探讨应用腹腔镜无张力疝修补术联合补中益气汤治疗腹股沟疝的临床效果。方法选择2020年1月—2021年12月的腹股沟疝患者90例作为观察对象,根据入院顺序随机分组,对照组(45例)接受单纯的腹腔镜无张力疝修补术治疗,研究组(45例)接受腹腔镜无张力疝修补术联合中药补中益气汤治疗,观察手术后两组的疼痛评分、住院时间、术后复发率及治疗前后中医证候评分。结果手术后,研究组疼痛评分、住院时间及术后复发率均明显低于对照组,各项中医证候评分和总分明显优于对照组(P<0.05)。两组患者术后并发症发生情况对比,差异无统计学意义(P>0.05)。结论针对腹股沟疝行腹腔镜无张力疝修补术联合补中益气汤治疗,可帮助患者有效缩短住院时间、缓解疼痛程度,并改善其中气不足表现、降低术后复发率,值得临床推广应用。 展开更多
关键词 狐疝 腹股沟疝 腹腔镜疝修补术 补中益气汤 中西医结合疗法
在线阅读 下载PDF
基于“一气周流”理论探讨从“中气”治疗多囊卵巢综合征
16
作者 高远 张景明 +1 位作者 佟雅婧 杨钊田 《陕西中医》 2025年第2期233-236,240,共5页
多囊卵巢综合征(PCOS)高发于育龄期女性,是一种现代多发性疾病,其病因尚不明确。基于黄元御“一气周流”理论,联系PCOS相关症状表现,分析得出PCOS病理机制在于中气升降失职引起周流不畅,进而产生气滞、痰凝、血瘀等一系列病理改变,导致... 多囊卵巢综合征(PCOS)高发于育龄期女性,是一种现代多发性疾病,其病因尚不明确。基于黄元御“一气周流”理论,联系PCOS相关症状表现,分析得出PCOS病理机制在于中气升降失职引起周流不畅,进而产生气滞、痰凝、血瘀等一系列病理改变,导致肥胖、月经不调、不孕、痤疮等临床表现。由此进一步提出以傅氏加味补中益气汤为基础方,在中药人工周期疗法的指导下循周期加减用药,即以调畅中气为本治疗PCOS的方法,以期为临床诊疗PCOS提供新思路,为PCOS患者提供更易接受且更具长远意义的治疗方案。 展开更多
关键词 多囊卵巢综合征 黄元御 一气周流 傅氏加味补中益气汤 中药人工周期疗法
在线阅读 下载PDF
补中益气汤联合3HRZE/9HRE抗结核化疗方案对肠结核患者的临床疗效
17
作者 刘玲 景凤英 邵小霞 《中成药》 北大核心 2025年第1期91-95,共5页
目的探讨补中益气汤联合3HRZE/9HRE抗结核化疗方案对肠结核患者的临床疗效。方法80例患者随机分为对照组和观察组,每组40例,对照组给予3HRZE/9HRE抗结核化疗方案,观察组在对照组基础上加用补中益气汤。检测临床疗效、中医证候评分、肠... 目的探讨补中益气汤联合3HRZE/9HRE抗结核化疗方案对肠结核患者的临床疗效。方法80例患者随机分为对照组和观察组,每组40例,对照组给予3HRZE/9HRE抗结核化疗方案,观察组在对照组基础上加用补中益气汤。检测临床疗效、中医证候评分、肠黏膜屏障功能指标(乳果糖、甘露醇、L/M、DAO)、胃肠功能激素(MTL、CCK、GAS、VIP)、Th17、Treg、Th17/Treg、不良反应发生率变化。结果观察组总有效率高于对照组(P<0.05),不良反应发生率更低(P<0.05)。治疗后,2组中医证候评分、乳果糖、L/M、DAO、CCK、GAS、VIP、Th17、Th17/Treg降低(P<0.05),MTL、Treg升高(P<0.05),以观察组更明显(P<0.05)。结论补中益气汤联合3HRZE/9HRE抗结核化疗方案可安全有效地缓解肠结核患者临床症状,提高肠胃功能,改善Th17/Treg免疫平衡。 展开更多
关键词 补中益气汤 3HRZE/9HRE抗结核化疗方案 肠结核 胃肠功能 Th17/Treg免疫平衡
在线阅读 下载PDF
补中益气汤对老年腹股沟疝腹腔镜修补术后免疫功能及预后的影响
18
作者 王芝 孙红双 《中华中医药学刊》 北大核心 2025年第3期185-188,共4页
目的探讨补中益气汤对老年腹股沟疝腹腔镜修补术患者免疫功能及预后的影响。方法选取该院收治的老年腹股沟疝患者96例,将纳入患者随机分为两组,每组各48例。两组患者均行腹腔镜腹股沟疝修补术,对照组在此基础上进行抗感染治疗,观察组在... 目的探讨补中益气汤对老年腹股沟疝腹腔镜修补术患者免疫功能及预后的影响。方法选取该院收治的老年腹股沟疝患者96例,将纳入患者随机分为两组,每组各48例。两组患者均行腹腔镜腹股沟疝修补术,对照组在此基础上进行抗感染治疗,观察组在对照组基础上联合补中益气汤治疗,治疗7 d,对比两组患者临床治疗效果、免疫功能、视觉模拟量表(visual analogue score,VAS)评分、肛门排气时间、下床活动时间、住院时间及术后并发症情况。结果对照组总有效率为87.50%显著低于观察组总有效率97.92%,且差异具有统计学意义(P<0.05);治疗3 d后,两组VAS评分均显著低于治疗前(P<0.05);组间比较差异无统计学意义;治疗7 d后,两组VAS评分均显著低于治疗前及治疗后3 d,观察组显著低于对照组(P<0.05);两组治疗后免疫球蛋白G(immunoglobulin G,IgG)、免疫球蛋白A(immunoglobulin A,IgA)、免疫球蛋白M(immunoglobulin M,IgM)水平均较治疗前提升显著(P<0.05),观察组改善显著优于对照组(P<0.05);观察组患者肛门排气、术后下床及术后住院时间均优于对照组(P<0.05);对照组并发症发生率为14.59%,观察组并发症发生率为2.08%,观察组显著低于对照组(P<0.05)。结论补中益气汤对老年腹股沟疝腹腔镜修补术患者具有良好的治疗效果,可提高患者免疫功能,促进患者康复,减轻并发症,安全性高,值得临床应用。 展开更多
关键词 补中益气汤 老年腹股沟疝 腹腔镜腹股沟疝修补术 免疫功能
在线阅读 下载PDF
常规西药联合补中益气汤加减治疗高龄髋部骨折术后疲劳综合征的临床效果
19
作者 杨锐 《中外医药研究》 2025年第6期90-92,共3页
目的:探究常规西药联合补中益气汤加减治疗高龄髋部骨折术后疲劳综合征(POFS)的效果。方法:选取重庆三峡医药高等专科学校附属中医院2021年1月—2024年8月收治的90例高龄髋部骨折POFS患者为研究对象,随机分为对照组、观察组,各45例。对... 目的:探究常规西药联合补中益气汤加减治疗高龄髋部骨折术后疲劳综合征(POFS)的效果。方法:选取重庆三峡医药高等专科学校附属中医院2021年1月—2024年8月收治的90例高龄髋部骨折POFS患者为研究对象,随机分为对照组、观察组,各45例。对照组采用常规西药治疗,观察组在对照组基础上联合补中益气汤加减治疗。分析治疗效果。结果:观察组总有效率高于对照组(P=0.015)。术后1、7、14 d,两组Christensen疲劳评分降低,观察组术后7、14 d的Christensen疲劳评分低于对照组(P<0.05)。术后1、7、14 d,两组血红蛋白浓度(HGB)低于术前1 d,观察组术后7、14 d的HGB高于对照组(P<0.05)。结论:常规西药联合补中益气汤加减治疗高龄髋部骨折POFS的效果确切,可有效缓解患者疲劳程度,促进HGB水平恢复。 展开更多
关键词 髋部骨折 术后疲劳综合征 补中益气汤 高龄
在线阅读 下载PDF
补中益气汤合血府逐瘀汤治疗冠心病合并心力衰竭的临床研究
20
作者 付晓星 赵明君 +1 位作者 陈伶利 胡建宏 《国际医药卫生导报》 2025年第1期75-79,共5页
目的评估补中益气汤合血府逐瘀汤治疗冠心病合并心力衰竭患者的疗效和安全性。方法本研究为回顾性研究。选取2022年1月至2023年6月铜川市中医医院心内科收治的140例冠心病合并心力衰竭患者,根据治疗方法的不同分为对照组与治疗组。对照... 目的评估补中益气汤合血府逐瘀汤治疗冠心病合并心力衰竭患者的疗效和安全性。方法本研究为回顾性研究。选取2022年1月至2023年6月铜川市中医医院心内科收治的140例冠心病合并心力衰竭患者,根据治疗方法的不同分为对照组与治疗组。对照组68例中男36例,女32例,年龄(58.31±8.07)岁,病程(6.55±3.07)年,接受心内科常规治疗。口服琥珀酸美托洛尔缓释片,初始剂量11.875~23.750 mg,1次/d;目标剂量190 mg,1次/d。治疗组72例中男37例,女35例,年龄(60.42±7.98)岁,病程(7.27±2.37)年,在对照组基础上使用补中益气汤合血府逐瘀汤治疗,早、晚饭后各温服200 ml,每日1剂,7 d为1个疗程。两组均连续治疗12周后评价疗效。评价指标包括纽约心脏病学会(NYHA)心功能分级、左心室射血分数(LVEF)、左心室收缩末期内径(LVESD)、左心室舒张末期内径(LVEDD)、6 min步行试验、心率、C反应蛋白及氨基末端脑肽钠前体(NT-proBNP)、生活质量评分和不良反应发生率。采用χ^(2)检验、t检验进行统计分析。结果治疗12周后,治疗组患者的总有效率为91.67%(66/72),对照组为75.00%(51/68),差异有统计学意义(χ^(2)=5.914,P=0.015);治疗组的LVEF、LVESD、LVEDD分别为(58.32±9.78)%、(40.67±6.01)mm、(45.10±6.69)mm,对照组上述指标分别为(47.67±8.98)%、(48.52±7.47)mm、(54.31±8.08)mm,差异均有统计学意义(t=-6.700、6.869、7.363,均P<0.001);治疗组的6 min步行试验距离、心率、C反应蛋白、NT-proBNP分别为(320.36±28.09)m、(73.31±13.52)次/min、(4.25±1.21)mg/L、(301.67±44.45)μg/L,对照组上述指标分别为(290.58±21.31)m、(82.41±10.44)次/min、(7.31±3.65)mg/L、(378.32±36.79)μg/L,差异均有统计学意义(t=-7.036、4.439、6.734、11.080,均P<0.001);治疗组世界卫生组织生存质量测定量表简表的生理、心理、环境、社会关系评分均高于对照组(均P<0.05)。治疗期间,治疗组不良反应发生率为12.50%(9/72),对照组为13.24%(9/68),差异无统计学意义(χ^(2)=0.124,P=0.971)。结论补中益气汤合血府逐瘀汤可以改善冠心病合并心力衰竭患者心功能,提高生活质量,且安全性良好。 展开更多
关键词 冠心病 心力衰竭 补中益气汤 血府逐瘀汤 临床研究
在线阅读 下载PDF
上一页 1 2 49 下一页 到第
使用帮助 返回顶部